Recognizing melanoma symptoms early can make the difference between a quick, straightforward treatment and a far more complex one. Melanoma is the most serious form of skin cancer because, unlike the more common skin cancers, it can spread to other parts of the body when it is not caught in time. The reassuring news is that most melanomas appear on the skin where they can be seen, and many are found early, often by people who simply noticed a mole that looked different from the rest. In this article you’ll learn how to spot the warning signs with the ABCDE rule, how doctors diagnose and stage the disease, which blood tests and biomarkers matter and when, and how melanoma treatment has changed in recent years. The aim is clear, calm information, not alarm.
Apa itu melanoma?
Melanoma is a cancer that begins in melanocytes, the cells that produce melanin, the pigment that gives skin its color. Because melanocytes are found mainly in the skin, most melanomas appear there, but they can occasionally develop in the eye, under a nail, or on the lining of the mouth or other internal surfaces. Melanoma accounts for a small share of all skin cancers, yet it causes the majority of skin cancer deaths because of its ability to spread, or metastasize, if left untreated.
Not all melanomas look the same. Understanding the main patterns helps explain why the warning signs can vary from one person to another.
The main types of melanoma
- Superficial spreading melanoma, the most common form, which tends to grow outward across the skin before growing downward.
- Nodular melanoma, a faster-growing, often raised and firm lesion that may be dark or, less commonly, lack pigment altogether.
- Lentigo maligna melanoma, which usually appears on sun-damaged skin in older adults, such as the face.
- Acral lentiginous melanoma, which develops on the palms, the soles of the feet, or under the nails, and can occur in people of any skin tone.
Melanoma symptoms: the ABCDE warning signs
The most useful tool for recognizing melanoma symptoms at home is the ABCDE rule. Each letter points to a feature that is more common in melanoma than in an ordinary mole. A spot does not need to show every feature to deserve attention, and any single change that is new or growing is worth a professional opinion.
| Tanda | What to look for |
|---|---|
| A — Asymmetry | One half of the spot does not match the other half. |
| B — Border | Edges are irregular, ragged, notched, or blurred rather than smooth. |
| C — Color | Several shades appear in one spot: brown, black, tan, and sometimes red, white, or blue. |
| D — Diameter | Larger than about 6 millimeters, roughly the width of a pencil eraser, though melanomas can be smaller. |
| E — Evolving | Any change over weeks or months in size, shape, color, or elevation, or new itching, bleeding, or crusting. |
Other warning signs
Dermatologists also watch for the “ugly duckling” sign: a mole that simply looks different from a person’s other moles. A new spot in adulthood, a sore that will not heal, a dark streak under a fingernail or toenail, or a change in a long-standing mole all deserve review. Harmless growths can look alarming, too. For a sense of how a common benign spot can be mistaken for cancer, read our comparison of seborrheic keratosis and melanoma.
Kapan harus menemui dokter?
Make an appointment with a clinician or dermatologist if you notice any of the following:
- A mole or spot that is changing in size, shape, or color.
- A new spot that looks different from your others, especially after age 30.
- A spot that itches, bleeds, oozes, or does not heal.
- A dark band under a nail that you cannot explain by an injury.
- Any lesion that worries you, even if it does not fit the ABCDE pattern neatly.
What causes melanoma, and who is at higher risk?
Melanoma develops when melanocytes acquire genetic damage that lets them grow out of control. The single largest modifiable cause is ultraviolet, or UV, radiation, from the sun and from tanning beds. According to the Centers for Disease Control and Prevention and the American Academy of Dermatology, protecting the skin from UV is the most effective way to lower risk.
Risk factors to know
- Repeated sunburns, especially blistering sunburns in childhood.
- Use of indoor tanning beds.
- Fair skin that burns easily, light eyes, and blond or red hair.
- A large number of moles (50 or more) or several atypical moles.
- A personal or family history of melanoma.
- A weakened immune system, for example after an organ transplant.
Older adults are diagnosed most often, but melanoma is also one of the more common cancers in younger adults, which is why the warning signs matter at every age. Having risk factors does not mean melanoma is inevitable, and many people with melanoma have only one or two of them.
How melanoma is diagnosed and staged
Diagnosing melanoma is a stepwise process that starts with the eye and ends with the microscope. No blood test can confirm or rule out melanoma; the diagnosis is made from a sample of the suspicious tissue.
Skin examination and dermoscopy
A clinician first examines the spot and often the whole skin surface. Many use dermoscopy, a handheld magnifier with polarized light that reveals patterns not visible to the naked eye, which improves accuracy and reduces unnecessary procedures.
Biopsy and histopathology
If a lesion is suspicious, the standard next step is a biopsy, usually removing the entire spot with a margin of normal skin. A pathologist then examines it under the microscope to confirm melanoma and to measure key features, including the Breslow thickness (how deep the melanoma reaches into the skin) and whether the surface is ulcerated. These details drive the stage and the plan.
Sentinel lymph node biopsy and imaging
For melanomas beyond a certain thickness, doctors may test the sentinel lymph node, the first node into which the area drains, to see whether cells have begun to spread. Imaging such as ultrasound, CT, PET-CT, or MRI is generally reserved for thicker melanomas or when spread is suspected, rather than for thin, early lesions. Staging combines tumor thickness, ulceration, lymph node status, and, when the disease is advanced, results from blood work.
Blood tests and biomarkers in melanoma
People often ask which blood test finds melanoma. The honest answer is that none does on its own, and melanoma has no routine screening blood test the way some cancers are followed with a protein marker. To understand what these markers can and cannot do, see our explainer on tumor markers. Instead, specific blood and tissue tests earn their place at particular moments, mainly to judge prognosis, guide treatment, or monitor advanced disease.
| Tes | Apa yang dilihatnya | When it usually matters |
|---|---|---|
| LDH (laktat dehidrogenase) | A general enzyme in the blood that can rise when tissue is under stress. | Advanced (stage IV) melanoma, as a prognostic marker built into staging. |
| S100B | A protein that tends to track with the amount of melanoma in the body. | Prognosis and monitoring in some centers, mainly in Europe. |
| BRAF mutation test | A genetic change in the tumor tissue, most often at a spot called V600. | Advanced or higher-risk disease, to decide whether targeted therapy can be used. |
| Circulating tumor DNA (ctDNA) | Tiny fragments of tumor DNA shed into the bloodstream. | Emerging use for monitoring advanced melanoma; not a screening test. |
LDH: a prognostic marker in advanced disease
Lactate dehydrogenase is an enzyme present in many tissues, so it is not specific to melanoma. In advanced melanoma, however, a raised LDH level is linked with a poorer outlook and is formally part of how stage IV disease is classified. It is used to help gauge prognosis and follow the disease, not to detect melanoma in the first place. To see how this enzyme is measured and reported, read our guide to the LDH blood test.
S100B: tracking tumor burden
S100B is a protein that often rises as the amount of melanoma in the body increases. In some countries it is measured to help estimate prognosis and to monitor people over time. It is a supporting marker rather than a diagnostic one, and its use varies from center to center.
BRAF mutation testing: a treatment key
About half of cutaneous melanomas carry a mutation in a gene called BRAF, most often a change known as V600. This test is performed on the tumor tissue, not on blood, and it matters because it opens the door to targeted therapy. Knowing the BRAF status of an advanced melanoma helps the team choose between treatment paths.
Circulating tumor DNA: the emerging liquid biopsy
Circulating tumor DNA is made of small pieces of DNA that a tumor sheds into the blood. Measuring it, sometimes called a liquid biopsy, is a fast-moving area of research aimed at spotting a returning melanoma earlier and reading how well treatment is working. These liquid biopsies are the same technology behind newer screening tools; for the bigger picture, read our overview of multi-cancer early-detection blood tests. Some cancers are tracked with a protein marker in the blood, though melanoma does not rely on one today; to see how that approach works, review our article on the CEA blood test.
How melanoma is treated
Treatment depends heavily on the stage. Early melanoma that has not spread is usually treated and cured with surgery alone, while advanced melanoma calls on a wider toolkit that has expanded dramatically over the past decade.
Operasi
Surgery is the mainstay for melanoma that is caught early. The surgeon removes the melanoma along with a margin of healthy skin, a procedure called wide local excision. When indicated, a sentinel lymph node biopsy is done at the same time to check for early spread.
Imunoterapi
Immunotherapy helps the immune system recognize and attack melanoma cells. The main class, called immune checkpoint inhibitors, includes drugs that block PD-1 (such as pembrolizumab and nivolumab) and a drug that blocks CTLA-4 (ipilimumab), sometimes given in combination. According to the National Cancer Institute, these medicines have transformed the outlook for many people with advanced melanoma.
Terapi target
For melanomas that carry a BRAF V600 mutation, targeted therapy can switch off the faulty growth signal. These treatments pair a BRAF inhibitor (such as dabrafenib or vemurafenib) with a MEK inhibitor (such as trametinib) to work better and longer together. This is why BRAF testing is done before choosing this path.
Radiation and supportive care
Radiation therapy may be used in specific situations, such as treating melanoma that has spread to the brain or relieving symptoms. During immunotherapy or targeted therapy, teams monitor routine labs; to see what those numbers track, read our explainer on the complete blood count. Care also includes managing side effects and supporting overall well-being.
Reducing your risk: prevention and follow-up
Because UV exposure is the leading modifiable cause, sun protection is the heart of prevention. The American Academy of Dermatology recommends seeking shade, wearing protective clothing and a wide-brimmed hat, and using a broad-spectrum sunscreen with SPF 30 or higher, while avoiding indoor tanning entirely.
Regular skin self-examinations help you learn what is normal for you, so a change stands out. Many clinicians suggest checking your skin monthly and seeing a professional for a skin exam based on your personal risk. Careful sun protection rarely causes vitamin D problems, but if you are concerned about your levels, read panduan kami tentang tes darah vitamin D. Found and treated early, melanoma is very often curable; the outlook becomes more serious once it spreads, which is exactly why noticing changes early is so valuable.
Latest scientific advances in melanoma
Melanoma research is moving quickly, and several recent findings are reshaping care. The points below are simplified for a general reader, and none of them replace advice from your own care team.
Immunotherapy before surgery
For melanoma that has reached nearby lymph nodes but can still be removed, a 2024 clinical trial found that giving immunotherapy before surgery, an approach called neoadjuvant treatment, kept more people cancer-free longer than giving it only after surgery. What this means for you: the timing of immunotherapy, not just the drug, is becoming part of the conversation for stage III melanoma.
Blood tests that watch for a return
Researchers are refining circulating tumor DNA tests to detect a melanoma coming back earlier than scans can, and to show sooner whether a treatment is working. What this means for you: these liquid biopsies are still used mainly in research and specialized centers rather than for routine screening, but they point to a future in which a simple blood draw could help monitor advanced melanoma.
Better ways to read prognosis
Beyond the long-established LDH test, scientists are studying additional blood markers, including proteins and immune signals, to predict more precisely how an individual melanoma will behave. What this means for you: today LDH and tissue-based BRAF testing remain the mainstays, while newer markers are still being validated and are not yet part of everyday care.
Glosarium
| Ketentuan | Definisi |
|---|---|
| Melanocyte | A skin cell that makes melanin, the pigment that colors skin, hair, and eyes. Melanoma begins in these cells. |
| ABCDE rule | A simple checklist (Asymmetry, Border, Color, Diameter, Evolving) for spotting moles that may be melanoma. |
| Dermoscopy | Examining the skin with a special magnifier and light to see patterns invisible to the naked eye. |
| Biopsi | Removing a sample of tissue, or the whole spot, so it can be examined under a microscope. |
| Breslow thickness | A measurement of how deeply a melanoma has grown into the skin, used to help set the stage. |
| Sentinel lymph node biopsy | A test of the first lymph node the area drains into, to check for early spread. |
| Metastasis | Penyebaran kanker dari tempat asalnya ke bagian tubuh lainnya. |
| Laktat dehidrogenase (LDH) | A blood enzyme used as a prognostic marker in advanced melanoma, not as a screening test. |
| BRAF mutation | A genetic change in the tumor that can be targeted with specific drugs; found in about half of cutaneous melanomas. |
| Circulating tumor DNA (ctDNA) | Fragments of tumor DNA in the blood, measured in a liquid biopsy to help monitor disease. |
Pertanyaan yang sering diajukan
What does early-stage melanoma look like?
Early melanoma is often a flat or barely raised spot that breaks the ABCDE rules: it may be asymmetric, have an uneven border, show more than one color, or simply be changing. It can be small, so size alone is not reassuring. Many early melanomas are painless, which is why appearance and change matter more than discomfort. If a spot looks different from your other moles or is evolving, have it checked rather than waiting for symptoms.
Can a blood test detect melanoma?
No single blood test can diagnose melanoma, and there is no routine blood screen for it. A diagnosis comes from a biopsy of the suspicious skin. Blood tests do play supporting roles: LDH helps judge prognosis in advanced disease, S100B is used in some centers to monitor tumor burden, and circulating tumor DNA is an emerging way to track advanced melanoma. These tests inform care once melanoma is known, rather than finding it first.
How is a mole different from melanoma?
A common mole is usually small, one even color, round or oval, with a smooth border, and it stays stable for years. Melanoma tends to be asymmetric, multicolored, irregularly bordered, larger, or changing over time. The “ugly duckling” that stands out from your other moles is a useful clue. Because some harmless growths can mimic melanoma, a dermatologist gives the definitive answer, often with dermoscopy and, if needed, a biopsy.
Does every melanoma patient need a BRAF test?
Not necessarily. BRAF testing is generally done for advanced or higher-risk melanoma, because its main purpose is to decide whether targeted therapy is an option. The test is performed on tumor tissue from the biopsy, not on a blood sample. Many people with thin, early melanoma that is fully removed by surgery do not need BRAF testing at all. Your oncologist recommends it when the result would change the treatment plan.
Is melanoma always life-threatening?
No. When melanoma is found and removed early, it is very often cured, and most people diagnosed at an early stage do well. The risk rises when melanoma grows deeper or spreads to lymph nodes or other organs, which is why early detection is so important. Even for advanced melanoma, modern immunotherapy and targeted therapy have improved outcomes considerably compared with a decade ago.
How often should I check my skin?
Many dermatologists suggest a monthly self-examination so you become familiar with your own moles and can notice changes. Use a mirror or ask for help to check hard-to-see areas such as the back, scalp, and soles. How often you need a professional skin exam depends on your risk factors, so people with many moles, fair skin, or a personal or family history of melanoma may be advised to be seen more regularly.
Sumber
- National Cancer Institute — Melanoma Treatment (PDQ), Patient Version — cancer.gov
- American Academy of Dermatology — Melanoma: overview and warning signs — aad.org
- American Cancer Society — Signs and Symptoms of Melanoma Skin Cancer — cancer.org
- Tasdogan et al. — Cutaneous melanoma — Nature Reviews Disease Primers, 2025 — doi.org/10.1038/s41572-025-00603-8
- Boutros et al. — The treatment of advanced melanoma: current approaches and new challenges — Critical Reviews in Oncology/Hematology, 2024 — doi.org/10.1016/j.critrevonc.2024.104276
- Castellani et al. — BRAF mutations in melanoma: biological aspects, therapeutic implications, and circulating biomarkers — Cancers, 2023 — doi.org/10.3390/cancers15164026
- Blank et al. — Neoadjuvant nivolumab and ipilimumab in resectable stage III melanoma — New England Journal of Medicine, 2024 — doi.org/10.1056/NEJMoa2402604
- Eroglu et al. — Circulating tumor DNA-based molecular residual disease detection for treatment monitoring in advanced melanoma — Cancer, 2023 — doi.org/10.1002/cncr.34716
- Kaleem et al. — Imaging and laboratory workup for melanoma — Oral and Maxillofacial Surgery Clinics of North America, 2022 — doi.org/10.1016/j.coms.2021.11.004
- Ding et al. — Prognostic biomarkers of cutaneous melanoma — Photodermatology, Photoimmunology & Photomedicine, 2022 — doi.org/10.1111/phpp.12770
Bacaan lebih lanjut
- How a blood test is done, step by step
- How long blood test results take
- Ruam kulit: penyebab, gejala, dan pengobatan
- Eczema: understanding the skin condition
- Psoriasis: gejala, jenis, penyebab, dan pemicunya
Pahami hasil lab Anda dengan AI DiagMe.
Dapatkan interpretasi hasil Anda dalam hitungan menit.
Melanoma reminds us how much a single change on the skin, or a single number on a lab report, can matter. If a melanoma workup brings blood tests such as LDH, a complete blood count, or an emerging circulating tumor DNA test, the results can be hard to read on paper. To make sense of the numbers, you can consult panduan kami untuk membaca hasil tes darah, and AI DiagMe can help you understand what your values mean in plain language. It is a tool to help you understand your results, not a way to diagnose melanoma, and it does not replace your doctor or dermatologist.
